Method of obtaining derivatives of dibenzimidasoazepine or salts thereof

专利摘要:
The method for producing derivatives; dibenzimidazoazepine, update the formulas where R is methyl, ethyl, isopropyl or allyl; R, is hydrogen or methyl; Pv, j is hydrogen, methyl or chlorine; .X - oxygen, sulfur or methylene; the dotted line indicates the presence of a single or double bond; or their hydrobromides or hydrochlorides, characterized in that the compound of the general formula O) where the dotted lines, the radicals R, B R, and X have the indicated meanings, is subjected to a binding procedure with cyanogen bromine in an organic solvent medium with an aftertreatment of the target product in in free form or as hydrochloride or hydrobromide. O1 00
公开号:SU1155158A3
申请号:SU823484887
申请日:1982-08-31
公开日:1985-05-07
发明作者:Вальтер Герхард；Шнейдер Клаус；Вебер Карл-Гейн；Фюгнер Армин
申请人:Берингер Ингельгейм Кг (Фирма)；
IPC主号:

专利说明:

The invention relates to a process for the preparation of new azepine derivatives with valuable pharmacological properties, in particular, to a process for the preparation of dibenzimidazoazepine derivatives of the general formula where R is methyl, ethyl, isoprolyl or allyl; hydrogen or methyl; hydrogen, methyl or chlorine; oxygen, sulfur or methylene, dotted line, means the presence of a simple or double bond. Or their hydrochlorides or hydrobromides possessing valuable pharmacological properties, in particular antiallergic activity. It is known the use of sodium with hromoglycinoxy acid (intal) as a tool with high antiallergic activity in. A known method for the preparation of imine derivatives of heterocyclic compounds by cyclization of the corresponding amino derivative with cyanogen bromine in an organic solvent, for example tetragndrofuran 2. The purpose of the invention is a method of obtaining new azepine derivatives of general formula (1) with valuable pharmacological properties. This goal is achieved by the fact that according to the method of obtaining dibenzimidazoazepine derivatives of fumugal (1), the compound of the general formula (1 where the dotted line, R, R Rj and X radicals give the indicated values, is subjected to the interaction with cyan bromine in an organic solvent medium followed by release of the target product in free form or as hydrochloride or hydrobromide. Example 1, 2-methyl-3-imino-1 hydrobromide, 2,9,13 L-tetrahydro-3-H-dibenz (c, J imidazo (1,5-a a) azepine (compound 1). Stirring, to a suspension of 7.15 g (0.03 mol) of 6-methylaminomethyl-6, 11-dihydro-5H-dibenz (b, e) azepine (formula TI; R, and R2 H; RX-CHj;; dashed line — simple bond) in 70 ml of absolute ethanol was added a solution of 3/2 g (0, 03 mol) of cyanogen bromide in 8 ml of absolute tetrahydrofuran. A slightly exothermic reaction forms a solution which is stirred at room temperature for 4 hours. Then the ether is added to the reaction solution. The resulting crystals are sucked off and dried. Output 8.6 g (83% of theoretical); m.p. 247-250 ° C. After re-crystallization from a mixture of methanol and ethyl acetate, the desired product was m.p. 247.-250 ° C. Example 2 2-methyl-3-11mino-2, 3-, chyhydro-9H dibenz hydrobromide. (c, f) -imidazo (1,) azepine (compound 2) ,. : To a solution of 44.4 g (0.188 mol) of 6-methylaminomethyl-morphantrieding (formula .C; dotted line double bond; R, and R2, and RX CHg), stirring and cooling with ice, add dropwise a solution of 19, 93 g (0.188 mol) of cyanogen bromide in 140 ml of absolute tetrahydrofuran. The reaction mixture is further stirred for 4 hours at room temperature and then ethyl acetate is added. Formed Ristals suck and. dried Yield 49.5 g (77% of theoretical); m.p. 287-289 ° C. After recrystallization from a mixture of ethanol and ksusnogo ether, the target product has. 291-293 p. Similarly, compounds -16 are obtained, summarized in table 1.
.Table 1
-GfljH
- CH, H
-S "5" -CHN- Double Allyl -Hgo-rCjHj. H Same-OT-H-S-, 44.4
51.7
63.5
(from methanol, ether), HBg bond
52.6 244-245 56.3 (from methanol, ether), HBr 291-294 69.8 (from acetonitrile), HBr 296-299 (from methanol, acetic acid. Ether), HBg 314-317 broke. (ie methanol, ethyl acetate), HBg
iiL iEiTzr iii i; i
12
6-CH N,
13 -CH.
6-CH H -S14-CH,
6-CH 12-CH -S15-SNB-CH-H -016
6-CH 12-C1 -0-CH,
Experiments on the study of antiallergic activity carried out on allergenic rats after passive sensitization of animals with antibodies and the subsequent provocation of antigen. Thus, passive anaphnpaxuo skin is induced. Data on the antiallergic activity of new compounds and the known product are summarized in table 2.
Table 2 3.9 50 4.3 3.9 2, 9 4.0
Continued table.
303-305 63.7 (from methanol, ethyl acetate)
327-328 71.8 (from methanol, ethyl acetate)
295-297 47.2 (from methanol, ethyl acetate)
257-259 69.0
growth (from methane sulfur, ethyl acetate)
about the same
288-298 49.9 (from methanol, ethyl acetate)
Continued table. 2
Inal 10.0
(known) Table 55 data. 2 indicate that the novel compounds are more active (the maximum effective dose of ED50 is 5.9 mg / kg) than is known. Studies on the study of antihistamine activity are carried out on rats, which cause a blister by intradermal injection of histamine. After extravasation of the Zvens blue dye into the skin, the volume of voldar is determined. The results of the experiments are summarized in table 3.
I 1551588
Table 3 Thus, the proposed method of action is ak-Tld; 7 Connectivity, Ed, o.mg / kg; mg / kg intravenous I Cheral Through the mouth but I mouth 1 (mx) i „OOP and, and / 1 / ou„ I1 ° allows to obtain new azepine derivatives of general formula (1) with valuable pharmacological properties, in particular antiallergic activity.

权利要求:
Claims (1)
[1]
A method of producing dibenzimidazoazepine derivatives of the general formula wherein R is methyl, ethyl, isopropyl or allyl;
R <is hydrogen or methyl;
R ₂ is hydrogen, methyl or chlorine;
X is oxygen, sulfur or methylene; dashed line means a single or double bond; or their hydrobromides or hydrochlorides, about t - characterized in that the compound of General formula
R where the dashed line, the radicals R, R |, R ₂ and X have the indicated meanings, are reacted with bromine cyan in an organic solvent medium, followed by isolation of the target product in free form or in the form of a hydrochloride or hydrobromide.

类似技术:

---

公开号 | 公开日 | 专利标题

---

CS9100906A2|1991-11-12|Substituted azoles, method of their production, preparations that contain these compounds and their application

---

EP0017484B1|1983-04-06|2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same

---

SU1155158A3|1985-05-07|Method of obtaining derivatives of dibenzimidasoazepine or salts thereof

---

US3978066A|1976-08-31|Certain 4,6-dihydropyrrolotriazoline-quinoline derivatives

---

EP0050458B1|1985-01-02|2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them

---

CH635586A5|1983-04-15|METHOD FOR PRODUCING 1,3-DIHYDROIMIDAZO | PYRIDIN-2-ONEN.

---

GB1566307A|1980-04-30|Indole derivatives of amides and amino esters and process for their manufacture

---

IE51946B1|1987-04-29|Imidazolylphenyl amidines

---

US4199588A|1980-04-22|6-Phenyl-4H-s-triazolo-[3,4c]-thieno-[2,3e]-1,4-diazepines and salts thereof

---

US3939161A|1976-02-17|1,3-Dimethyl- 1H-pyrazolo| pyrimidine-7 |-ones

---

US3480630A|1969-11-25|2-arylhydrazino-imidazolines-| and salts thereof

---

US3816422A|1974-06-11|2,3-dihydro-oxo-imidazo|pyrimidines and salts thereof

---

US5049637A|1991-09-17|1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepino derivatives and 10-aza, 10-oxa and 10-thia analogues

---

KOSASAYAMA et al.1979|Cyclic guanidines. IV. Synthesis of hypoglycemic N-benzhydryl bicyclic guanidines

---

US3928380A|1975-12-23|1,1{40 -Spirobis|

---

US4053600A|1977-10-11|Tricyclic 1,2,4-triazolo-quinazolines

---

US3530140A|1970-09-22|Certain pyridyl-hydrazino-2-yl-imidazolines

---

US4042583A|1977-08-16|Imidazo[2,1-b]thiazole and thiazolo[3,2-a]-benzimidazole quaternary salts as hypoglycemic agents and growth promotants

---

US4968708A|1990-11-06|Imidazo[2,1-B]benzothiazole compounds and antiulcer compositions containing the same

---

US4152440A|1979-05-01|Novel derivatives of imidazole, and pharmaceutical compositions containing them

---

US4213986A|1980-07-22|Novel derivatives of imidazole and pharmaceutical compositions containing them and method of use

---

US4808727A|1989-02-28|Imidazolium hydrogen carbonates

---

US4096140A|1978-06-20|5-Amino or substituted amino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepines

---

IE50570B1|1986-05-14|2-phenylamino-imidazolines-|,compositions and processes for the preparation thereof

---

US3936459A|1976-02-03|1&#39;,4&#39;-Dihydro-1-methyl-spiro [piperidine and pyrrolidine-2,3&#39;|quinoline]-2&#39;-one compounds

同族专利:

---

公开号 | 公开日

---

GB2108112A|1983-05-11|

---

ES515413A0|1983-08-16|

---

ES8308330A1|1983-08-16|

---

GB2108112B|1985-01-09|

---

NZ201780A|1986-01-24|

---

US4503060A|1985-03-05|

---

FI76089C|1988-09-09|

---

EP0073506A1|1983-03-09|

---

DK391182A|1983-03-03|

---

FI76089B|1988-05-31|

---

IL66694D0|1982-12-31|

---

PH19377A|1986-04-02|

---

GR77274B|1984-09-11|

---

KR840001577A|1984-05-07|

---

AT18049T|1986-03-15|

---

PT75494A|1982-10-01|

---

JPH0380795B2|1991-12-26|

---

IE54261B1|1989-08-02|

---

AU8792682A|1984-03-08|

---

ZA826380B|1984-05-30|

---

CS236680B2|1985-05-15|

---

YU196082A|1984-12-31|

---

CA1169858A|1984-06-26|

---

DE3269187D1|1986-03-27|

---

PL135812B1|1985-12-31|

---

DK160047C|1991-06-10|

---

KR880001988B1|1988-10-10|

---

FI823001L|1983-03-03|

---

DD204255A5|1983-11-23|

---

DE3134672A1|1983-03-17|

---

DK160047B|1991-01-21|

---

EP0073506B1|1986-02-19|

---

ES521604A0|1984-05-16|

---

ES8405017A1|1984-05-16|

---

AU550340B2|1986-03-20|

---

ES521605A0|1984-05-16|

---

NO160445C|1989-04-19|

---

PT75494B|1986-04-17|

---

YU43089B|1989-02-28|

---

HU185110B|1984-12-28|

---

NO822948L|1983-03-03|

---

IE822131L|1983-03-02|

---

JPS5846089A|1983-03-17|

---

PL238090A1|1984-01-02|

---

NO160445B|1989-01-09|

---

FI823001A0|1982-08-31|

---

ES8405018A1|1984-05-16|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

BE789410A|1971-10-05|1973-01-15|Akzo Nv|NIEUWE IMIDAZOLIDINE DERIVATEN|

---

NL7202963A|1972-03-07|1973-09-11|

---

NL7414038A|1974-10-28|1976-05-03|Akzo Nv|NEW TETRACYCLIC PYRROLIDINO DERIVATIVES.|

---

DE3008944A1|1980-03-08|1981-09-24|C.H. Boehringer Sohn, 6507 Ingelheim|DIBENZIMIDAZOAZEPINE, THEIR PRODUCTION AND USE|AU692300B2|1993-11-22|1998-06-04|Merck & Co., Inc.|2,3-dihydro-1--2-oxo-5-phenyl-1h-1, 4-benzodiazepines|

---

EP0730581B1|1993-11-22|2001-10-04|Merck & Co. Inc.|3-acylaminobenzazepines|

---

US5478934A|1994-11-23|1995-12-26|Yuan; Jun|Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands|

---

US5631251A|1995-06-07|1997-05-20|Merck & Co., Inc.|5-cyclopropyl-1,4 benzodiazepine-2-ones|

---

US5691331A|1995-06-07|1997-11-25|Merck & Co., Inc.|N- -3- amides|

---

US5700797A|1995-06-07|1997-12-23|Merck & Co, Inc.|N--3-amides|

---

AU720378B2|1995-06-07|2000-06-01|Merck & Co., Inc.|Novel N--3-amides|

---

US5726171A|1995-06-07|1998-03-10|Merck & Co Inc|N--acetamides|

---

SG170044A1|2006-03-31|2011-04-29|Vistakon Pharmaceuticals Llc|Ocular allergy treatments|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

DE19813134672|DE3134672A1|1981-09-02|1981-09-02|HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE|

---